Metabolic Disorders in Multiple Myeloma
Multiple myeloma (MM) is the second most common hematological malignancy and is attributed to monoclonal proliferation of plasma cells in the bone marrow. Cancer cells including myeloma cells deregulate metabolic pathways to ensure proliferation, growth, survival and avoid immune surveillance, with...
Enregistré dans:
Auteurs principaux: | Maria Gavriatopoulou, Stavroula A. Paschou, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/09e31b8548c4455aae403a9d8e95af86 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Advances in improving mammalian cells metabolism for recombinant protein production
par: Altamirano,Claudia, et autres
Publié: (2013) -
Nitric Oxide Circumvents Virus-Mediated Metabolic Regulation during Human Cytomegalovirus Infection
par: Rebekah L. Mokry, et autres
Publié: (2020) -
Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1
par: Hongxia Zhang, et autres
Publié: (2021) -
Macroglossia reveals multiple myeloma
par: Maria Bonvicini, et autres
Publié: (2021) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
par: E. A. Senkina, et autres
Publié: (2014)